Pharmacogenomics

This should encompass:

research in pharmacogenetics, particularly genotyping of polyorphs relevent to pharmacotherapy contributing to the establishment of genetic mapping for the population.

the application of gene chip technology in the development of tests to screen for patients who are potentially at risk.

the development of enzyme based tests, utilizing biotechnology, for the elucidation of metabolic pathway of biomolecules.

development towards virtual clinical trials based on the research in the preceding components.